TIGIT/PVR and LncRNA ANRIL Dual-targetable PAMAM Polymeric Nanoparticles Efficiently Inhibited the Hepatoma Carcinoma by Combination of Immunotherapy and Gene Therapy

A Novel D Peptide Identified by Mirror‐image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy

(2020) Xiuman Zhou et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Nanoparticle‐mediated double‐stranded RNA delivery system: A promising approach for sustainable pest management

(2020) Shuo Yan et al.   Insect Science

Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro

(2019) Guowei Li et al.   PATHOLOGY RESEARCH AND PRACTICE

LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144

(2019) Yongbiao Ma et al.   ANTI-CANCER DRUGS

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer

(2018) Yujiao Xie et al.   Molecular Oncology

Association between long non-coding RNAs expression and pathogenesis and progression of gliomas (Review)

(2018) Jie Zhou et al.   Oncology Letters

Upregulation of SOX2-activated lncRNA ANRIL promotes nasopharyngeal carcinoma cell growth

(2018) Jian-Hui Wu et al.   Scientific Reports

Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer

(2018) Hauke Stamm et al.   MAMMALIAN GENOME

Effect of lncRNA ANRIL silencing on anoikis and cell cycle in human glioma via microRNA-203a

(2018) Weiying Dai et al.   OncoTargets and Therapy

Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies

(2018) Hongshu Sui et al.   Journal of Immunology Research

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy

(2017) William C. Dougall et al.   IMMUNOLOGICAL REVIEWS

Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment

(2017) Qiaohong Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant

(2017) Ming J. Poi et al.   MOLECULAR CARCINOGENESIS

The diagnosis and treatment of hepatocellular carcinoma

(2017) Justin Hartke et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas

(2016) Yu Zhu et al.   Oncotarget

Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis

(2015) Ling Lin et al.   Diagnostic Pathology

The evolving epidemiology of hepatocellular carcinoma: a global perspective

(2015) Michael C Wallace et al.   Expert Review of Gastroenterology & Hepatology

Recent Advances in Nanoparticle-Mediated siRNA Delivery

(2014) John-Michael Williford et al.   Annual Review of Biomedical Engineering

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles

(2013) Mark J. Ernsting et al.   JOURNAL OF CONTROLLED RELEASE

Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery

(2013) Sneha A. Kulkarni et al.   PHARMACEUTICAL RESEARCH

Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a

(2010) Kyoko L. Yap et al.   MOLECULAR CELL

The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress

(2009) Wei Wang et al.   NANOTECHNOLOGY